Poster 40
- Kelley Tangredi
- May 10, 2024
- 1 min read
Updated: Jun 27, 2024
Nemolizumab monotherapy improves itch, sleep disturbance, and skin lesions in patients with moderate-to-severe prurigo nodularis: Pooled analyses from OLYMPIA 1 and OLYMPIA 2 phase 3 studies
Authors: Gil Yosipovitch, Sonja Ständer, Martin Metz, Andrew E. Pink, Jonathan I. Silverberg, Howard Sofen, Faiz Ahmad, Aliene Noda, Zarif K. Jabbar Lopez, Christophe Piketty, Shawn G. Kwatra

Poster 40